[25-011918] thomas friedman, PI at nidcd requires preparation of a custom rabbit antiserum against a synthetic peptide sequence of part of human tprn (taperin) protein in order to research experiments…
Ended Purchase Order Awarded Last action
- Contract number
- 75N92025P00262
- Awardee
-
Labcorp Early Development Laboratories Inc. UEI ERNEDJQ5T7A5
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,336
Award facts
- Contract value 100% obligated
- $10,335.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53704, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $10,336 |
About this award
The National Heart Lung and Blood Institute awarded a $10,335.86 firm fixed-price purchase order to Labcorp Early Development Laboratories Inc., a Madison, Wisconsin-based subsidiary of Laboratory Corporation of America Holdings, to support research conducted by Thomas Friedman, Principal Investigator at the National Institute on Deafness and Other Communication Disorders (NIDCD). The contract involves the preparation of custom rabbit antiserum targeting a synthetic peptide sequence derived from the human TPRN (taperin) protein, which will be utilized for immunolocalization experiments. This non-set-aside purchase order is scheduled for completion by July 7, 2026, following its award on July 8, 2025.
Labcorp Early Development Laboratories Inc. specializes in providing advanced scientific research support services to federal agencies within the National Institutes of Health ecosystem, with particular expertise in polyclonal antibody production and complex laboratory services. The vendor's federal contract portfolio demonstrates extensive experience delivering specialized biological and medical research support across multiple NIH institutes, making it well-positioned to meet the technical requirements of this custom antiserum development project. This engagement reflects the company's established capabilities in producing high-quality immunological reagents for fundamental biomedical research applications.
Description
[25-011918] thomas friedman, PI at nidcd requires preparation of a custom rabbit antiserum against a synthetic peptide sequence of part of human tprn (taperin) protein in order to research experiments on the immunolocalization of tprn
Quick answers
Who was awarded contract 75N92025P00262?
75N92025P00262 was awarded to Labcorp Early Development Laboratories Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on July 8, 2025.
How much is contract 75N92025P00262 worth?
The government has obligated $10,336 on 75N92025P00262.
Was contract 75N92025P00262 competed?
The extent of competition for 75N92025P00262 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award